Model
Edge
Chromocell Therapeutics
CHRO
Filing Type
8-K
Filing Date
11/6/2025
Updated
11/7/25, 6:01 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Material Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sales of Equity Securities, Other Events
EX-4.1
EXHIBIT 4.1
EX-10.1
EXHIBIT 10.1
EX-10.2
EXHIBIT 10.2
EX-10.3
EXHIBIT 10.3
EX-10.4
EXHIBIT 10.4
EX-10.5
EXHIBIT 10.5
EX-10.6
EXHIBIT 10.6
EX-10.7
EXHIBIT 10.7
EX-10.8
EXHIBIT 10.8
EX-99.1
Material Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sales of Equity Securities, Other Events
GRAPHIC
Graphic